Insufficient evidence for a role of SERPINF1 in otosclerosis.


Journal

Molecular genetics and genomics : MGG
ISSN: 1617-4623
Titre abrégé: Mol Genet Genomics
Pays: Germany
ID NLM: 101093320

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 14 09 2018
accepted: 01 04 2019
pubmed: 11 4 2019
medline: 30 7 2019
entrez: 11 4 2019
Statut: ppublish

Résumé

Otosclerosis is a common form of hearing loss (HL) due to abnormal remodeling of the otic capsule. The genetic causes of otosclerosis remain largely unidentified. Only mutations in a single gene, SERPINF1, were previously published in patients with familial otosclerosis. To unravel the contribution of genetic variation in this gene to otosclerosis, this gene was re-sequenced in a large population of otosclerosis patients and controls. Resequencing of the 5' and 3' UTRs, coding regions, and exon-intron boundaries of SERPINF1 was performed in 1604 unrelated otosclerosis patients and 1538 unscreened controls, and in 62 large otosclerosis families. Our study showed no enrichment of rare variants, stratified by type, in SERPINF1 in patients versus controls. Furthermore, the c.392C > A (p.Ala131Asp) variant, previously reported as pathogenic, was identified in three patients and four controls, not replicating its pathogenic nature. We could also not find evidence for a pathogenic role in otosclerosis for 5' UTR variants in the SERPINF1-012 transcript (ENST00000573763), described as the major transcript in human stapes. Furthermore, no rare variants were identified in the otosclerosis families. This study does not support a pathogenic role for variants in SERPINF1 as a cause of otosclerosis. Therefore, the etiology of the disease remains largely unknown and will undoubtedly be the focus of future studies.

Identifiants

pubmed: 30968248
doi: 10.1007/s00438-019-01558-8
pii: 10.1007/s00438-019-01558-8
doi:

Substances chimiques

3' Untranslated Regions 0
5' Untranslated Regions 0
Eye Proteins 0
Nerve Growth Factors 0
Serpins 0
pigment epithelium-derived factor 0

Types de publication

Journal Article

Langues

eng

Pagination

1001-1006

Subventions

Organisme : Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) program
ID : IAP P7/43-BeMGI
Organisme : Agentschap voor Innovatie door Wetenschap en Technologie
ID : 131526
Organisme : Fonds Wetenschappelijk Onderzoek
ID : 12D1717N

Références

Am J Hum Genet. 2001 Feb;68(2):495-500
pubmed: 11170898
Otol Neurotol. 2001 Sep;22(5):596-602
pubmed: 11568664
J Med Genet. 2002 Jul;39(7):473-7
pubmed: 12114476
J Med Genet. 2004 Jun;41(6):450-3
pubmed: 15173231
Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):416-24
pubmed: 16618911
Eur J Hum Genet. 2007 Mar;15(3):362-8
pubmed: 17213839
Hum Mol Genet. 2007 Sep 1;16(17):2021-30
pubmed: 17588962
J Bone Miner Res. 2008 Apr;23(4):507-16
pubmed: 18021008
Hum Genet. 2008 Apr;123(3):267-72
pubmed: 18224337
Otol Neurotol. 2008 Apr;29(3):295-301
pubmed: 18491423
Am J Hum Genet. 2009 Mar;84(3):328-38
pubmed: 19230858
PLoS Genet. 2009 May;5(5):e1000481
pubmed: 19436704
Am J Hum Genet. 2011 Mar 11;88(3):362-71
pubmed: 21353196
Clin Genet. 2011 May;79(5):495-7
pubmed: 21470211
Bioinformatics. 2012 Feb 1;28(3):421-2
pubmed: 22138362
Bioinformatics. 2014 Sep 15;30(18):2670-2
pubmed: 24867941
Am J Otol. 1989 Nov;10(6):426-38
pubmed: 2692453
Hum Mol Genet. 2016 Jun 15;25(12):2393-2403
pubmed: 27056980
Genet Med. 2019 May;21(5):1199-1208
pubmed: 30287925
Hum Mol Genet. 1998 Feb;7(2):285-90
pubmed: 9425236
Am J Otol. 1998 Sep;19(5):604-10
pubmed: 9752968

Auteurs

Hanne Valgaeren (H)

Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, Wilrijk, 2610, Antwerp, Belgium.

Manou Sommen (M)

Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, Wilrijk, 2610, Antwerp, Belgium.

Matthias Beyens (M)

Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, Wilrijk, 2610, Antwerp, Belgium.

Geert Vandeweyer (G)

Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, Wilrijk, 2610, Antwerp, Belgium.

Isabelle Schrauwen (I)

Molecular and Human Genetics Department, Center for Statistical Genetics, Baylor College of Medicine, Houston, TX, USA.

Anne Schepers (A)

Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, Wilrijk, 2610, Antwerp, Belgium.

Isabelle Schatteman (I)

European Institute for ORL, St-Augustinus Hospital Antwerp, Antwerp, Belgium.

Vedat Topsakal (V)

Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium.

Ingeborg Dhooge (I)

Department of Otolaryngology, Ghent University Hospital, Ghent, Belgium.

Henricus Kunst (H)

Department of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.

Diego Zanetti (D)

Department of Clinical Sciences and Community Health, Audiology Unit, University of Milan, I.R.C.C.S. Fondazione "Cà Granda", Osp.le Maggiore Policlinico, Milan, Italy.

Alexander M Huber (AM)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.

Alexander Hoischen (A)

Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.

Erik Fransen (E)

Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, Wilrijk, 2610, Antwerp, Belgium.
StatUa Center for Statistics, University of Antwerp, Antwerp, Belgium.

Guy Van Camp (G)

Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Universiteitsplein 1, Wilrijk, 2610, Antwerp, Belgium. guy.vancamp@uantwerpen.be.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH